The study found some patients do not respond to traditional treatments.
But in a clinical trial, the new drug, RG 7204, that comes in a pill form got positive results.
Doctors say this is not a cure, but it is a way to treat the skin cancer that is seeing some success.
Instead of ten percent success in treatment, they are now seeing up to eighty percent success.
For more information on this trial you can contact the cancer center clinical trial hotline at (888) 798-0719.
The web site is www.cancer.ucla.edu